Sort
50,496 grants matching “lung cancer”
The UCLA - Boston University Lung Cancer Biomarker Development Laboratory
$647,222Steven M. Dubinett · University Of California Los Angeles · U01 · FY2012 · CA
Streamlined and comprehensive circulating tumor exosome profiling by microfluidic arrayed nanoplasmonic sensors and actuators
$647,192Wei-Chuan Shih · University Of Houston · R01 · FY2025 · EB
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care:I-CARE
$647,172Korey A Kennelty · University Of Iowa · R01 · FY2017 · HL
EFIRM-Liquid Biopsy (eLB): Ultrasensitive ctDNA and miRNA Detection for Early Assessment of Lung Cancer
$647,157David T Wong · University Of California Los Angeles · U01 · FY2022 · CA
Evaluating the implementation and impact of navigator-delivered ePRO home symptom monitoring and management
$647,154Gabrielle Rocque · University Of Alabama At Birmingham · R01 · FY2021 · NR
Deciphering the role of EYA3/PP2A in triple negative breast cancer metastasis
$647,118Heide L Ford · University Of Colorado Denver · R01 · FY2025 · CA
Biochemistry Core
$647,039Duck-Yeon Lee · National Heart, Lung, And Blood Institute · ZIC · FY2025 · HL
Characterization of FGFR4 mutations in Rhabdomyosarcoma
$646,939Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Identification of Genes and DNA Methylation Markers for Lung Cancer Risk by Integrating Multi-omics Data
$646,885Qiuyin Cai · Vanderbilt University Medical Center · R01 · FY2024 · CA
Novel roles of RNA modifications in the pathogenesis of pulmonary vascular remodeling and PAH
$646,874You-Yang Zhao · Lurie Children'S Hospital Of Chicago · R01 · FY2024 · HL
Validating and Characterizing a New Melanoma Therapeutic Target
$646,803Sara A Courtneidge · Oregon Health & Science University · R01 · FY2017 · CA
Precision Lung Cancer Survivorship Care Intervention: A Randomized Controlled Trial Serving Rural Survivors and Communities
$646,688Jamie L Studts · University Of Colorado Denver · R01 · FY2021 · CA
Providing Tobacco Treatment to Patients Undergoing Lung Cancer Screening at MedStar Health: A Randomized Trial
$646,635Kathryn L Taylor · Georgetown University · R01 · FY2025 · CA
Pre-clinical evaluation of DT-001, a small molecule antagonist of MD2-TLR4 for utility in the treatment of pain.
$646,527Tony L Yaksh · Douleur Therapeutics, Inc. · R41 · FY2019 · NS
Structural and molecular determinants of protein phosphatase 2A function in lung cancer
$646,511Goutham Narla · University Of Michigan At Ann Arbor · R01 · FY2019 · CA
Understanding the role of structural racism on racial/ethnic inequities in lung cancer risk
$646,486Iona C Cheng · University Of California, San Francisco · R01 · FY2023 · CA
Occupational Exposure Assessment
$646,414Melissa Friesen · Division Of Cancer Epidemiology And Genetics · ZIA · FY2016 · CA
A non-invasive gene-expression biomarker of airway response to tobacco exposure
$646,408Avrum E Spira · Boston University Medical Campus · U01 · FY2007 · ES
Using MRI and circulating tumor DNA to improve the interpretation of response to immunotherapy and targeted therapy in CNS metastases
$646,356Elizabeth Gerstner · Massachusetts General Hospital · R01 · FY2024 · CA
Assessing Toxicant Properties of Cigarillo and Hookah Aerosols in Lung Epithelial and Cardiac Cells Through Aerosol Exposure
$646,355Steven A Belinsky · Lovelace Biomedical & Environmental Research Institute · R01 · FY2019 · ES
MTA1 in Oncogenesis
$646,348Rakesh Kumar · George Washington University · R01 · FY2009 · CA
Use of advanced imaging techniques to improve diagnostic methods for ARDS
$646,344Ednan K. Bajwa · Massachusetts General Hospital · R01 · FY2014 · HL
Comparative Effectiveness of Limited Resection vs. Stereotactic Body Radiation Therapy for Early Stage Lung Cancer
$646,326Juan P Wisnivesky · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · CA
Project 2: Next-Generation Mixed Chimerism Induction for Heart Allograft Tolerance
$646,162Leslie S Kean · Massachusetts General Hospital · P01 · FY2023 · HL
Project 2: Next-Generation Mixed Chimerism Induction for Heart Allograft Tolerance
$646,162Leslie S Kean · Massachusetts General Hospital · P01 · FY2025 · HL